Palisades Hudson Asset Management, L.P. Pfizer Inc Transaction History

Palisades Hudson Asset Management, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$32.09 - $37.51 $1,732 - $2,025	-54 Reduced 0.75%	7,157 $237,000
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $90,227 - $104,391	-2,498 Reduced 25.73%	7,211 $265,000
Q1 2023 Apr 26, 2023	SELL	$39.39 - $51.28 $35,569 - $46,305	-903 Reduced 8.51%	9,709 $396,000
Q4 2022 Feb 08, 2023	BUY	$41.75 - $54.5 $3,465 - $4,523	83 Added 0.79%	10,612 $544,000
Q3 2022 Oct 28, 2022	SELL	$43.76 - $53.42 $70,628 - $86,219	-1,614 Reduced 13.29%	10,529 $461,000
Q2 2022 Aug 10, 2022	BUY	$46.53 - $55.17 $80,962 - $95,995	1,740 Added 16.73%	12,143 $636,000
Q1 2019 Apr 23, 2019	SELL	$37.5 - $41.2 $262,725 - $288,647	-7,006 Reduced 40.24%	10,403 $442,000
Q3 2018 Nov 08, 2018	SELL	$34.47 - $41.81 $97,446 - $118,196	-2,827 Reduced 13.97%	17,409 $767,000
Q3 2017 Nov 06, 2017	BUY	$31.0 - $34.15 $627,316 - $691,059	20,236	20,236 $722,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Palisades Hudson Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Palisades Hudson Asset Management, L.P. with notifications on news.